Barriers to health care services for migrants living with HIV in SpainPatricia Ndumbi, Margarita Robau, J del Romero et al.|European Journal of Public Health|2017Cited by 45
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIVAna Gonzalez‐Cordón, Juergen Rockstroh, Julie Fox et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 27
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravirAna Gonzalez‐Cordón, Juergen Rockstroh, Lambert Assoumou et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 2